Saravolatz, L. D.
4 papers on CoChatORCID 0000-0002-7711-7915
Most cited papers
- Verified
Amphotericin B: time for a new “gold standard”
Saravolatz, L. D., Ostrosky-Zeichner, L., Marr, K. A., Rex, J. H., & Cohen, S. H. (2003) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 406
- Verified
Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine
Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy
Cited by 343
- Verified
Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections: A New Source for Nosocomial Outbreaks
SARAVOLATZ, L. D., POHLOD, D. J., & ARKING, L. M. (1982) · Annals of Internal Medicine
Antimicrobial Resistance in StaphylococcusInfection Control in Healthcare
Cited by 290
- Verified
Failure of Therapy in Pseudomonas Endocarditis: Selection of Resistant Mutants
Jimenez-Lucho, V. E., Saravolatz, L. D., Medeiros, A. A., & Pohlod, D. (1986) · Journal of Infectious Diseases
Infective Endocarditis Diagnosis and ManagementAntibiotic Resistance in Bacteria
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free